4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0001209191-17-015981
Chief Operating Officer sold 465 shares at $2.61 ($1,214)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Keuer Thomas A Chief Operating Officer | 2017-02-28 | Sale | −465 | $2.61 | $1,214 | 14,435 | D |
| Derivatives | |||||||
| Keuer Thomas A Chief Operating Officer | 2017-02-27 | Grant or award · Stock Option (right to buy) | +23,800 | 23,800 | D | ||
| Open-market sales · 465 sh · avg $2.61 · $1,214 | |||||||
Loading xslF345X03/doc4.xml…